Beriplast P Combi-Set

Indonesia • Dexa Medica


Supportive treatment where standard surgical techniques are insufficient such as for improvement of haemostasis, as a tissue glue to promote adhesion or sealing, or as suture support.


  • Fibrinogen concentrate for Beriplast P (lyophilized powder) 174 mg
  • Aprotinin solution for Beriplast P (diluent) 1 ml
  • Human thrombin for Beriplast P (lyophilized powder) 7.6 mg
  • Calcium chloride solution for Beriplast P (diluent) 1 ml


2 vials of powder and 2 vials of diluent

Dosage Forms

Powder and Solvent for Sealant

ATC Classification



Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Safe if Prescribed
This item is safe for use while operating heavy machinery.
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
This item may not be safe for use during lactation. Use with caution and after consultation with your doctor.


0 to 18 Years Old

The safety and efficacy of Beriplast in children and adolescents has not yet been established in controlled clinical studies.

18 Years Old and Above

The volume of Beriplast to be applied and the frequency of application should always be oriented towards the underlying clinical needs of the patient.

The dose to be applied is governed by variables including, but not limited to, the type of surgical intervention, the size of the area and the mode of intended application, and the number of applications.

Application of the product must be individualised by the treating physician. The individual dosages have typically ranged from 0.5 to 4 ml. For some procedures (e.g. liver traumata, or the sealing of large burned surfaces) larger volumes (10 ml or more) may be required.

The initial volume of the product to be applied at a chosen anatomic site or target surface area should be sufficient to entirely cover the intended application area. The application can be repeated, if necessary.